GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (OTCPK:CRLBF) » Definitions » Cyclically Adjusted PB Ratio

Cresco Labs (Cresco Labs) Cyclically Adjusted PB Ratio : (As of May. 21, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cresco Labs Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Cresco Labs's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Cyclically Adjusted PB Ratio Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cresco Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cresco Labs's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Cyclically Adjusted PB Ratio falls into.



Cresco Labs Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cresco Labs's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Cresco Labs's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.471/131.7762*131.7762
=1.471

Current CPI (Mar. 2024) = 131.7762.

Cresco Labs Quarterly Data

Book Value per Share CPI Adj_Book
201404 -26.286 100.023 -34.631
201407 -27.147 100.520 -35.588
201410 -27.147 100.176 -35.711
201501 -25.539 98.604 -34.131
201504 -27.636 99.824 -36.482
201507 -22.666 100.691 -29.664
201510 -22.867 100.346 -30.029
201601 -21.890 99.957 -28.858
201604 -24.820 100.947 -32.400
201607 -24.390 101.524 -31.658
201610 -23.959 101.988 -30.957
201701 -26.458 102.456 -34.029
201704 -25.797 103.167 -32.951
201707 -28.727 103.278 -36.654
201710 -28.268 104.070 -35.794
201801 -30.566 104.578 -38.516
201804 -29.963 105.708 -37.352
201807 -26.228 106.324 -32.507
201810 -0.243 106.695 -0.300
201903 1.077 107.251 1.323
201906 1.029 108.070 1.255
201909 1.329 108.329 1.617
201912 1.422 108.420 1.728
202003 3.033 108.902 3.670
202006 2.871 108.767 3.478
202009 2.823 109.815 3.388
202012 2.118 109.897 2.540
202103 2.520 111.754 2.971
202106 3.299 114.631 3.792
202109 2.447 115.734 2.786
202112 2.599 117.630 2.912
202203 2.479 121.301 2.693
202206 2.675 125.017 2.820
202209 2.622 125.227 2.759
202212 2.082 125.222 2.191
202303 2.012 127.348 2.082
202306 1.854 128.729 1.898
202309 1.500 129.860 1.522
202312 1.489 129.419 1.516
202403 1.471 131.776 1.471

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cresco Labs  (OTCPK:CRLBF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cresco Labs Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Cresco Labs's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cresco Labs (Cresco Labs) Business Description

Traded in Other Exchanges
Address
400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.